| Regulation of adiposity by dietary calcium. | |
| | |
MedLine Citation:
|
PMID: 10834935 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Recent data from this laboratory demonstrate that increasing adipocyte intracellular Ca(2+) results in a coordinated stimulation of lipogenesis and inhibition of lipolysis. We have also noted that increasing dietary calcium of obese patients for 1 year resulted in a 4.9 kg loss of body fat (P<0.01). Accordingly, we tested the possibility that calcitrophic hormones may act on adipocytes to increase Ca(2+) and lipid metabolism by measuring the effects of 1, 25-(OH)(2)-D in primary cultures of human adipocytes, and found significant, sustained increases in intracellular Ca(2+) and a corresponding marked inhibition of lipolysis (EC(50) approximately 50 pM; P<0.001), suggesting that dietary calcium could reduce adipocyte mass by suppressing 1,25-(OH)(2)-D. To test this hypothesis, we placed transgenic mice expressing the agouti gene specifically in adipocytes on a low (0.4%) Ca/high fat/high sucrose diet either unsupplemented or with 25 or 50% of the protein replaced by non-fat dry milk or supplemented to 1.2% Ca with CaCO(3) for 6 wk. Weight gain and fat pad mass were reduced by 26-39% by the three high calcium diets (P<0.001). The high calcium diets exerted a corresponding 51% inhibition of adipocyte fatty acid synthase expression and activity (P<0.002) and stimulation of lipolysis by 3. 4- to 5.2-fold (P<0.015). This concept of calcium modulation of adiposity was further evaluated epidemiologically in the NHANES III data set. After controlling for energy intake, relative risk of being in the highest quartile of body fat was set to 1.00 for the lowest quartile of Ca intake and was reduced to 0.75, 0.40, and 0.16 for the second, third, and fourth quartiles, respectively, of calcium intake for women (n=380;P<0.0009); a similar inverse relationship was also noted in men (n=7114; P<0.0006). Thus, increasing dietary calcium suppresses adipocyte intracellular Ca(2+) and thereby modulates energy metabolism and attenuates obesity risk. |
| | |
Authors:
|
M B Zemel; H Shi; B Greer; D Dirienzo; P C Zemel |
Related Documents
:
|
21540035 - The effect of dietary nickel on the immune responses of spodoptera litura fabricius lar... 9159275 - The effect of microbial phytase in a pearl millet-soybean meal diet on apparent digesti... 20118415 - Effect of reduced dietary calcium concentration and phytase supplementation on calcium ... 2335575 - Persistently elevated parathyroid hormone secretion and action in young women after fou... 12884095 - Topographical electrogastrograms after radical esophagectomy with colonic replacement. 16504615 - Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction wit... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: FASEB journal : official publication of the Federation of American Societies for Experimental Biology Volume: 14 ISSN: 0892-6638 ISO Abbreviation: FASEB J. Publication Date: 2000 Jun |
Date Detail:
|
Created Date: 2000-07-12 Completed Date: 2000-07-12 Revised Date: 2012-02-15 |
Medline Journal Info:
|
Nlm Unique ID: 8804484 Medline TA: FASEB J Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1132-8 Citation Subset: IM |
Affiliation:
|
Department of Nutrition, The University of Tennessee, Knoxville, Tennessee 37996-1900, USA. mzemel@utk.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adipocytes
/
cytology,
drug effects*,
enzymology,
metabolism Adult Agouti Signaling Protein Animals Blood Glucose / analysis Body Temperature / drug effects Calcium / metabolism* Calcium, Dietary / administration & dosage, pharmacology*, therapeutic use Cells, Cultured Dairy Products Energy Intake Energy Metabolism / drug effects Fatty Acid Synthetase Complex / genetics, metabolism Female Humans Insulin / blood Intercellular Signaling Peptides and Proteins* Lipolysis / drug effects* Male Mice Mice, Transgenic Obesity / blood, diet therapy, metabolism Parathyroid Hormone / antagonists & inhibitors, pharmacology Proteins / genetics, metabolism Vitamin D / antagonists & inhibitors, pharmacology Weight Gain / drug effects |
| Chemical | |
Reg. No./Substance:
|
0/Agouti Signaling Protein; 0/Blood Glucose; 0/Calcium, Dietary; 0/Insulin; 0/Intercellular Signaling Peptides and Proteins; 0/Parathyroid Hormone; 0/Proteins; 1406-16-2/Vitamin D; 7440-70-2/Calcium; EC 6.-/Fatty Acid Synthetase Complex |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Co-localization of TFF3 peptide and oxytocin in the human hypothalamus.
Next Document: Entamoeba histolytica disturbs the tight junction complex in human enteric T84 cell layers.